54 results
Page 2 of 3
8-K
EX-1.1
u465qnr1
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
ipm673xh43hvtq
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
nkvzyhqwj1ql
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
6wd1irdmm9
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
kk82xq
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
wtlavw
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
9fpwc
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
EX-99.1
gem5wrtg
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
8-K
u8kv pt2pri4h17p9uia
30 May 19
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
xc8uuyawc8cu kf6sf
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
DEF 14A
zmx9iq0ghv0u
30 Apr 19
Definitive proxy
4:04pm
10-K
h5icf
22 Mar 19
Annual report
4:45pm
424B4
p5z77x gnnm4cc
8 Feb 19
Prospectus supplement with pricing info
4:40pm
CORRESP
abts lg5anw9f5
5 Feb 19
Correspondence with SEC
12:00am